Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146223 · ClinicalTrials.gov registry record
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 10
- Enrollment target
NCT01146223: Completed study, sponsored by Children's Oncology Group.
NCT01146223 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01146223 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This research study is studying biomarkers in patients with acute promyelocytic leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and about biomarkers related to cancer.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-06 |
What the finished NCT01146223 record still lists
NCT01146223 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01146223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01146223 about?
NCT01146223 is a clinical study titled "Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia". This research study is studying biomarkers in patients with acute promyelocytic leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and about biomarkers related to cancer.
What is the current status of trial NCT01146223?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01146223?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01146223?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia